These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 32123106)

  • 21. New strategy for renal fibrosis: Targeting Smad3 proteins for ubiquitination and degradation.
    Wang X; Feng S; Fan J; Li X; Wen Q; Luo N
    Biochem Pharmacol; 2016 Sep; 116():200-9. PubMed ID: 27473774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tubulin Resists Degradation by Cereblon-Recruiting PROTACs.
    Gasic I; Groendyke BJ; Nowak RP; Yuan JC; Kalabathula J; Fischer ES; Gray NS; Mitchison TJ
    Cells; 2020 Apr; 9(5):. PubMed ID: 32349222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential PROTAC substrate specificity dictated by orientation of recruited E3 ligase.
    Smith BE; Wang SL; Jaime-Figueroa S; Harbin A; Wang J; Hamman BD; Crews CM
    Nat Commun; 2019 Jan; 10(1):131. PubMed ID: 30631068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PROTACs: An Emerging Targeting Technique for Protein Degradation in Drug Discovery.
    Gu S; Cui D; Chen X; Xiong X; Zhao Y
    Bioessays; 2018 Apr; 40(4):e1700247. PubMed ID: 29473971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sequential replication-coupled destruction at G1/S ensures genome stability.
    Coleman KE; Grant GD; Haggerty RA; Brantley K; Shibata E; Workman BD; Dutta A; Varma D; Purvis JE; Cook JG
    Genes Dev; 2015 Aug; 29(16):1734-46. PubMed ID: 26272819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HaloPROTACS: Use of Small Molecule PROTACs to Induce Degradation of HaloTag Fusion Proteins.
    Buckley DL; Raina K; Darricarrere N; Hines J; Gustafson JL; Smith IE; Miah AH; Harling JD; Crews CM
    ACS Chem Biol; 2015 Aug; 10(8):1831-7. PubMed ID: 26070106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PHOTACs Enable Optical Control of Protein Degradation.
    Reynders M; Trauner D
    Methods Mol Biol; 2021; 2365():315-329. PubMed ID: 34432252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemically ubiquitylated PCNA as a probe for eukaryotic translesion DNA synthesis.
    Chen J; Ai Y; Wang J; Haracska L; Zhuang Z
    Nat Chem Biol; 2010 Apr; 6(4):270-2. PubMed ID: 20208521
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proteolysis-targeting chimeras for targeting protein for degradation.
    Qi J; Zhang G
    Future Med Chem; 2019 Apr; 11(7):723-741. PubMed ID: 30706727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted degradation of PCNA outperforms stoichiometric inhibition to result in programed cell death.
    Chang SC; Gopal P; Lim S; Wei X; Chandramohan A; Mangadu R; Smith J; Ng S; Gindy M; Phan U; Henry B; Partridge AW
    Cell Chem Biol; 2022 Nov; 29(11):1601-1615.e7. PubMed ID: 36318925
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidermal growth factor receptor protects proliferating cell nuclear antigen from cullin 4A protein-mediated proteolysis.
    Lo YH; Ho PC; Wang SC
    J Biol Chem; 2012 Aug; 287(32):27148-57. PubMed ID: 22692198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PROTAC-mediated crosstalk between E3 ligases.
    Steinebach C; Kehm H; Lindner S; Vu LP; Köpff S; López Mármol Á; Weiler C; Wagner KG; Reichenzeller M; Krönke J; Gütschow M
    Chem Commun (Camb); 2019 Feb; 55(12):1821-1824. PubMed ID: 30672516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeted protein degradation: expanding the toolbox.
    Schapira M; Calabrese MF; Bullock AN; Crews CM
    Nat Rev Drug Discov; 2019 Dec; 18(12):949-963. PubMed ID: 31666732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lessons in PROTAC Design from Selective Degradation with a Promiscuous Warhead.
    Bondeson DP; Smith BE; Burslem GM; Buhimschi AD; Hines J; Jaime-Figueroa S; Wang J; Hamman BD; Ishchenko A; Crews CM
    Cell Chem Biol; 2018 Jan; 25(1):78-87.e5. PubMed ID: 29129718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monitoring and deciphering protein degradation pathways inside cells.
    Daniels DL; Riching KM; Urh M
    Drug Discov Today Technol; 2019 Apr; 31():61-68. PubMed ID: 31200861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemically Induced Cellular Proteolysis: An Emerging Therapeutic Strategy for Undruggable Targets.
    Moon S; Lee BH
    Mol Cells; 2018 Nov; 41(11):933-942. PubMed ID: 30486612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PCNA-dependent ubiquitination of Cdt1 and p21 in mammalian cells.
    Hayashi A; Suenaga N; Shiomi Y; Nishitani H
    Methods Mol Biol; 2014; 1170():367-82. PubMed ID: 24906324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibody targeting of E3 ubiquitin ligases for receptor degradation.
    Marei H; Tsai WK; Kee YS; Ruiz K; He J; Cox C; Sun T; Penikalapati S; Dwivedi P; Choi M; Kan D; Saenz-Lopez P; Dorighi K; Zhang P; Kschonsak YT; Kljavin N; Amin D; Kim I; Mancini AG; Nguyen T; Wang C; Janezic E; Doan A; Mai E; Xi H; Gu C; Heinlein M; Biehs B; Wu J; Lehoux I; Harris S; Comps-Agrar L; Seshasayee D; de Sauvage FJ; Grimmer M; Li J; Agard NJ; de Sousa E Melo F
    Nature; 2022 Oct; 610(7930):182-189. PubMed ID: 36131013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeted protein degradation: elements of PROTAC design.
    Paiva SL; Crews CM
    Curr Opin Chem Biol; 2019 Jun; 50():111-119. PubMed ID: 31004963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conformational Flexibility of Ubiquitin-Modified and SUMO-Modified PCNA Shown by Full-Ensemble Hybrid Methods.
    Powers KT; Lavering ED; Washington MT
    J Mol Biol; 2018 Dec; 430(24):5294-5303. PubMed ID: 30381149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.